BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 31216473)

  • 1. GR and LSD1/KDM1A-Targeted Gene Activation Requires Selective H3K4me2 Demethylation at Enhancers.
    Clark EA; Wu F; Chen Y; Kang P; Kaiser UB; Fang R; Shi YG
    Cell Rep; 2019 Jun; 27(12):3522-3532.e3. PubMed ID: 31216473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The malignant brain tumor (MBT) domain protein SFMBT1 is an integral histone reader subunit of the LSD1 demethylase complex for chromatin association and epithelial-to-mesenchymal transition.
    Tang M; Shen H; Jin Y; Lin T; Cai Q; Pinard MA; Biswas S; Tran Q; Li G; Shenoy AK; Tongdee E; Lin S; Gu Y; Law BK; Zhou L; Mckenna R; Wu L; Lu J
    J Biol Chem; 2013 Sep; 288(38):27680-27691. PubMed ID: 23928305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Class I lysine deacetylases promote glucocorticoid-induced transcriptional repression through functional interaction with LSD1.
    Patrick NM; Griggs CA; Icenogle AL; Gilpatrick MM; Kadiyala V; Jaime-Frias R; Smith CL
    J Steroid Biochem Mol Biol; 2017 Mar; 167():1-13. PubMed ID: 27645313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A specific LSD1/KDM1A isoform regulates neuronal differentiation through H3K9 demethylation.
    Laurent B; Ruitu L; Murn J; Hempel K; Ferrao R; Xiang Y; Liu S; Garcia BA; Wu H; Wu F; Steen H; Shi Y
    Mol Cell; 2015 Mar; 57(6):957-970. PubMed ID: 25684206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LSD1 promotes S-phase entry and tumorigenesis via chromatin co-occupation with E2F1 and selective H3K9 demethylation.
    He Y; Zhao Y; Wang L; Bohrer LR; Pan Y; Wang L; Huang H
    Oncogene; 2018 Jan; 37(4):534-543. PubMed ID: 28991226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of KDM1A suppresses tumour migration and invasion by epigenetically regulating the TIMP1/MMP9 pathway in papillary thyroid cancer.
    Zhang W; Sun W; Qin Y; Wu C; He L; Zhang T; Shao L; Zhang H; Zhang P
    J Cell Mol Med; 2019 Aug; 23(8):4933-4944. PubMed ID: 31211500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysine-specific demethylase 1 has dual functions as a major regulator of androgen receptor transcriptional activity.
    Cai C; He HH; Gao S; Chen S; Yu Z; Gao Y; Chen S; Chen MW; Zhang J; Ahmed M; Wang Y; Metzger E; Schüle R; Liu XS; Brown M; Balk SP
    Cell Rep; 2014 Dec; 9(5):1618-1627. PubMed ID: 25482560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation of histone H3T6 by PKCbeta(I) controls demethylation at histone H3K4.
    Metzger E; Imhof A; Patel D; Kahl P; Hoffmeyer K; Friedrichs N; Müller JM; Greschik H; Kirfel J; Ji S; Kunowska N; Beisenherz-Huss C; Günther T; Buettner R; Schüle R
    Nature; 2010 Apr; 464(7289):792-6. PubMed ID: 20228790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KDM1A maintains genome-wide homeostasis of transcriptional enhancers.
    Agarwal S; Bonefas KM; Garay PM; Brookes E; Murata-Nakamura Y; Porter RS; Macfarlan TS; Ren B; Iwase S
    Genome Res; 2021 Feb; 31(2):186-197. PubMed ID: 33414108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KDM1A triggers androgen-induced miRNA transcription via H3K4me2 demethylation and DNA oxidation.
    Yang S; Zhang J; Zhang Y; Wan X; Zhang C; Huang X; Huang W; Pu H; Pei C; Wu H; Huang Y; Huang S; Li Y
    Prostate; 2015 Jun; 75(9):936-46. PubMed ID: 25728837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conventional and pioneer modes of glucocorticoid receptor interaction with enhancer chromatin in vivo.
    Johnson TA; Chereji RV; Stavreva DA; Morris SA; Hager GL; Clark DJ
    Nucleic Acids Res; 2018 Jan; 46(1):203-214. PubMed ID: 29126175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A UTX-MLL4-p300 Transcriptional Regulatory Network Coordinately Shapes Active Enhancer Landscapes for Eliciting Transcription.
    Wang SP; Tang Z; Chen CW; Shimada M; Koche RP; Wang LH; Nakadai T; Chramiec A; Krivtsov AV; Armstrong SA; Roeder RG
    Mol Cell; 2017 Jul; 67(2):308-321.e6. PubMed ID: 28732206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LSD1 Mediates Neuronal Differentiation of Human Fetal Neural Stem Cells by Controlling the Expression of a Novel Target Gene, HEYL.
    Hirano K; Namihira M
    Stem Cells; 2016 Jul; 34(7):1872-82. PubMed ID: 27018646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LSD1-ERRα complex requires NRF1 to positively regulate transcription and cell invasion.
    Zhang L; Carnesecchi J; Cerutti C; Tribollet V; Périan S; Forcet C; Wong J; Vanacker JM
    Sci Rep; 2018 Jul; 8(1):10041. PubMed ID: 29968728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression, Purification, and Biochemical Analysis of the LSD1/KDM1A Histone Demethylase.
    Laurent B; Shi Y
    Methods Enzymol; 2016; 573():241-59. PubMed ID: 27372756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression.
    Wissmann M; Yin N; Müller JM; Greschik H; Fodor BD; Jenuwein T; Vogler C; Schneider R; Günther T; Buettner R; Metzger E; Schüle R
    Nat Cell Biol; 2007 Mar; 9(3):347-53. PubMed ID: 17277772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RBPJ/CBF1 interacts with L3MBTL3/MBT1 to promote repression of Notch signaling via histone demethylase KDM1A/LSD1.
    Xu T; Park SS; Giaimo BD; Hall D; Ferrante F; Ho DM; Hori K; Anhezini L; Ertl I; Bartkuhn M; Zhang H; Milon E; Ha K; Conlon KP; Kuick R; Govindarajoo B; Zhang Y; Sun Y; Dou Y; Basrur V; Elenitoba-Johnson KS; Nesvizhskii AI; Ceron J; Lee CY; Borggrefe T; Kovall RA; Rual JF
    EMBO J; 2017 Nov; 36(21):3232-3249. PubMed ID: 29030483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysine-Specific Demethylase 1 (LSD1/KDM1A) Is a Novel Target Gene of c-Myc.
    Nagasaka M; Tsuzuki K; Ozeki Y; Tokugawa M; Ohoka N; Inoue Y; Hayashi H
    Biol Pharm Bull; 2019; 42(3):481-488. PubMed ID: 30828079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting histone demethylase LSD1 for treatment of deficits in autism mouse models.
    Rapanelli M; Williams JB; Ma K; Yang F; Zhong P; Patel R; Kumar M; Qin L; Rein B; Wang ZJ; Kassim B; Javidfar B; Couto L; Akbarian S; Yan Z
    Mol Psychiatry; 2022 Aug; 27(8):3355-3366. PubMed ID: 35296809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oct4-Mediated Inhibition of Lsd1 Activity Promotes the Active and Primed State of Pluripotency Enhancers.
    AlAbdi L; Saha D; He M; Dar MS; Utturkar SM; Sudyanti PA; McCune S; Spears BH; Breedlove JA; Lanman NA; Gowher H
    Cell Rep; 2020 Feb; 30(5):1478-1490.e6. PubMed ID: 32023463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.